Targeting tumor neovasculature in non-small-cell lung cancer.
about
Nintedanib in NSCLC: evidence to date and place in therapyTargeting Notch to overcome radiation resistanceFollowing the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapyIdentification of novel vascular targets in lung cancer.Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment.NADPH oxidase biology and the regulation of tyrosine kinase receptor signaling and cancer drug cytotoxicityMolecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized TherapyCombination use of paclitaxel and avastin enhances treatment effect for the NSCLC patients with malignant pleural effusion.Angiogenesis in NSCLC: is vessel co-option the trunk that sustains the branches?Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.The effect of Lfcin-B on non-small cell lung cancer H460 cells is mediated by inhibiting VEGF expression and inducing apoptosis.Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology.Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials.Recruitment of CD11b+Ly6C+ monocytes in non-small cell lung cancer xenografts challenged by anti-VEGF antibody.Endothelial Dll4-Notch signaling in tumor microenvironment: is there any hidden therapeutic opportunity?
P2860
Q26745424-97640711-A546-4C5F-936A-C5041FEB494BQ26771701-CAE48682-F7A7-4A95-8593-AE4A0AADB191Q35200424-1B699DCF-BCB2-405C-A6A6-19DAF3016F98Q35677838-892F2DC2-046F-4F79-9379-5610E4AC8E54Q36064738-2FB5FB64-0A8C-466B-AE9D-45E9EABC46FFQ36656128-D9F26F64-70A3-4DC1-BE89-FDBD4188ABC3Q37347532-3EB1ECA2-A1D8-4121-A348-59CE9814C00EQ37468177-179944FF-8F3D-42B8-AD89-15298DE440F5Q38763633-2C1D2183-D16F-44F3-A95F-12FBCC0EBC5DQ38943409-1B408212-E70E-4C0A-9DF4-3F8993180F3BQ38964908-18A0EB4B-F65F-4800-B153-5346DCB38B17Q39009241-1C1B29B2-8165-47CC-84B4-A8539F7634D1Q39305041-CA51AE5A-1691-4069-B939-2A0339E9E3D0Q40403877-9B9D94A7-BE6E-4967-A04A-79F8C84D1EF3Q40978947-F9ECE33F-CDD3-4986-9D5B-4A134B78CFB7Q41166648-4ED7148C-0893-4F20-AFA8-B6536FF4CAF3
P2860
Targeting tumor neovasculature in non-small-cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeting tumor neovasculature in non-small-cell lung cancer.
@en
type
label
Targeting tumor neovasculature in non-small-cell lung cancer.
@en
prefLabel
Targeting tumor neovasculature in non-small-cell lung cancer.
@en
P1476
Targeting tumor neovasculature in non-small-cell lung cancer.
@en
P2093
Athanasios G Pallis
Konstantinos N Syrigos
P304
P356
10.1016/J.CRITREVONC.2012.10.003
P577
2012-11-15T00:00:00Z